AWARD OF DBT-JUNIOR RESEARCH FELLOWSHIP (DBT-JRF) IN BIOTECHNOLOGY at National Centre for Cell Science
Applications are invited from Indian nationals for the award of “DBT-Junior Research Fellowship” (DBT-JRF) for pursuing research in frontier areas of Biotechnology and Applied Biology. JRFs will be selected according to merit under two categories: Category I & II. Category I fellowship (Top 275 in number) are tenable in any University/Institute in India where the students can register for Ph.D. Category II students (100 in number) will be eligible to join any DBT sponsored Project and avail fellowship equivalent to NET/GATE qualifications as per DST Guidelines, subject to selection through institutional selection process. Fellowship will be co-terminus with the duration of project and institutional rules will be applicable. There will be no binding on PIs of DBT sponsored projects to select JRF/SRF for their projects from category II list. Selection in Category II will not entitle student for any fellowship from DBT-JRF programme.
Post: Junior Research Fellowship

The expert committee submitted report to ministry of health and family welfare, Government of India on amendment of relevant rules in the Drugs and Cosmetics Act 1940 to include stem cells and other cell based products (SCCPs) as New Drugs.
The USFDA approved Chelsea Therapeutics's product Northera capsules (droxidopa), orphan-product, for the treatment of neurogenic orthostatic hypotension (NOH) which is rare, chronic and often debilitating drop in blood pressure upon standing that is associated with Parkinson's disease, multiple-system atrophy,

